Video

Lee Schwamm, MD

Publish date: March 3, 2016

Dr. Schwamm discusses results from MR WITNESS, a phase II trial of IV alteplase in patients with unwitnessed acute stroke using MRI to determine treatment eligibility.

 

References

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Intranasal Drug Delivery Bypasses the Blood–Brain Barrier
MDedge Neurology
Conference News Roundup—International Stroke Conference 2016
MDedge Neurology
VIDEO: Intracranial warfarin bleeds smaller with prothrombin complex instead of FFP
MDedge Neurology
VIDEO: A better way to treat large intraventricular hemorrhages
MDedge Neurology
Prestroke Antiplatelet Therapy Confers Benefits and Risks
MDedge Neurology
Is Task-Oriented Stroke Rehab Better Than Usual Rehab?
MDedge Neurology
ISC: Thrombectomy shown highly cost-effective for stroke
MDedge Neurology
Aspirin May Not Prevent Stroke in Patients With Atrial Fibrillation
MDedge Neurology
VIDEO: Hands-off yields best brain arteriovenous malformation outcomes
MDedge Neurology
ISC: Pick up extra AF with extended Holter monitoring
MDedge Neurology

Related Articles